When should diazepam be administered to a child with tetanus?

Diazepam Administration in Pediatric Tetanus

Diazepam should be initiated immediately upon diagnosis of tetanus in children to control muscle spasms and rigidity, with dosing based on age and severity of symptoms.

Dosing Guidelines by Age

Based on FDA-approved labeling, the specific dosing for tetanus in children is 1:

Infants over 30 days of age:

• 1-2 mg IM or IV slowly
• Repeat every 3-4 hours as necessary

Children 5 years or older:

• 5-10 mg IM or IV
• Repeat every 3-4 hours as necessary to control tetanus spasms
• Larger doses may be required in severe cases

Critical Administration Requirements

Respiratory assistance must be readily available before administering diazepam for tetanus 1. The IV route is strongly preferred, administered slowly (at least 1 minute per 5 mg given) to minimize respiratory depression 1.

Key Safety Considerations:

• Inject deeply into muscle if IM route is used
• Avoid small veins (dorsum of hand/wrist)
• Do not mix or dilute with other solutions
• Monitor closely for apnea, particularly in the first 3-5 days when fatal complications are most likely 2

High-Dose Regimens for Severe Cases

Research evidence supports escalating doses in severe tetanus:

• Neonatal tetanus: Continuous IV infusion of 20-40 mg/kg/day has shown 89% survival (2/19 mortality) 3
• Severe pediatric tetanus: Doses up to 480 mg/day have been used successfully, though mechanical ventilation should be available when exceeding 240 mg/day 4
• Therapeutic serum level: Minimum 500 ng/mL for effective spasm control 5

Clinical Decision Algorithm

1. Immediate initiation: Start diazepam as soon as tetanus is diagnosed—do not delay
2. Age-appropriate dosing: Use FDA guidelines above as starting point
3. Titrate to effect: Increase dose every 3-4 hours based on spasm control
4. Monitor for complications: Watch for respiratory depression, severe drowsiness, apneic episodes 3
5. Escalate if needed: If spasms persist despite standard dosing, consider high-dose regimens with ventilatory support

Evidence Strength

Diazepam alone is superior to phenobarbitone/chlorpromazine combinations (RR for death 0.36,95% CI 0.15-0.86), resulting in milder clinical course and shorter hospitalization 6. This Cochrane review, while noting methodological limitations of available trials, supports diazepam as first-line therapy.

Common Pitfalls to Avoid:

• Delaying treatment while awaiting laboratory confirmation—clinical diagnosis is sufficient
• Underdosing due to fear of respiratory depression—inadequate spasm control increases mortality
• Using IM route when IV is feasible—IV provides more reliable control
• Administering without respiratory support available—this is contraindicated 1

Note: Diazepam is not approved for neonates ≤30 days due to inability to metabolize the drug, leading to prolonged CNS depression 1. Alternative management strategies are required for this age group.